Proshrs Ulsht Nq Bio (BIS) 39.14 $BIS Finally A Biotech

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 2:20 AM

Proshrs Ulsht Nq Bio (BIS) 39.14 $BIS

Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 39.14 (+1.60), FBT: 92.77 (-2.34), XBI: 55.67 (-1.30), IBB: 267.60 (-5.98), LABD: 35.92 (+2.34)

Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 39.14 (+1.60), FBT: 92.77 (-2.34), XBI: 55.67 (-1.30), IBB: 267.60 (-5.98), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

BlackIce Completes the Implementation of Basel II Using the ERA Solution with Vietnam International Bank (VIB)
ACCESSWIRE - Wed Mar 30, 10:19PM CDT
VANCOUVER, BC / ACCESSWIRE / March 30, 2016 / BlackIce Enterprise Risk Management (CSE: BIS) ("BlackIce"

announces the implementation of the Basel II Project utilizing the BlackIce Enterprise Risk Aggregation (ERA™) solution with the Vietnam International Commercial Bank (VIB).
BIS: 39.14 (+1.60)

The Fed’s LMCI Drops for Second Consecutive Month
Chuck Butler - Daily Reckoning - Tue Mar 08, 9:36AM CST
This post The Fed’s LMCI Drops for Second Consecutive Month appeared first on Daily Reckoning . The Fed's very own Labor Markets Condition Index fell 2.4 points in February - the largest monthly drop since 2009 - despite the so-called...
BIS: 39.14 (+1.60), RBA: 33.50 (-1.13)

Top ETF Stories of February
Zacks Equity Research - ZACKS - Tue Mar 01, 5:03AM CST
Inside the top ETF stories of February that pulled the strings in the investing world throughout the month.
PTF: 37.85 (-0.59), KRE: 40.53 (-0.57), EFZ: 33.87 (+0.97), BIS: 39.14 (+1.60), DTYL: 82.03 (+0.17), IGV: 105.47 (-1.48), SQQQ: 18.21 (+0.58), GLD: 121.74 (+0.49), FXY: 90.60 (+0.23), EUFN: 17.52 (-0.81)

Two Big Factors Hurting Biotech ETFs
ETFtrends.com - ETF Trends - Tue Oct 06, 3:39PM CDT
Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas of the market Tuesday. The iShares Nasdaq...
SBIO: 24.50 (-0.70), BIS: 39.14 (+1.60), FBT: 92.77 (-2.34), PTH: 45.20 (-0.74), IBB: 267.60 (-5.98), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
BIS: 39.14 (+1.60), VRX: 24.14 (-1.34), IBB: 267.60 (-5.98), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

Where Do Biotech ETFs Go From Here?
ETFtrends.com - ETF Trends - Tue Sep 29, 2:49PM CDT
Biotechnology stocks and related exchange traded funds gave back all of their gains this year and then some, and the sector may experience even more pain ahead. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by...
BIS: 39.14 (+1.60), IBB: 267.60 (-5.98), RXD: 46.55 (+1.59), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

How to Short Biotechnology Stocks with ETFs
Sweta Killa - Zacks Investment Research - Tue Sep 29, 9:17AM CDT
Here are the three ETF ways to play the bearish trend in the biotech sector.
BIS: 39.14 (+1.60), VRX: 24.14 (-1.34), IBB: 267.60 (-5.98), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 39.14 (+1.60), BIB: 42.23 (-1.95), UBIO: 24.32 (-1.66), LABU: 31.80 (-2.20), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

Clinton Delivers Poison Pill To Biotech ETFs
ETFtrends.com - ETF Trends - Mon Sep 21, 1:27PM CDT
If you’re on team Hillary Clinton in the upcoming presidential election, you might want to trim down exposure to biotechnology stocks and sector-related exchange traded funds. “Price gouging like this in the specialty drug market is...
SBIO: 24.50 (-0.70), BIS: 39.14 (+1.60), BBC: 19.82 (-0.54), XBI: 55.67 (-1.30), IBB: 267.60 (-5.98), RXD: 46.55 (+1.59), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

This Is The Week! Finally!
Chuck Butler - Daily Reckoning - Mon Sep 14, 9:26AM CDT
This post This Is The Week! Finally! appeared first on Daily Reckoning . The week is finally here when the FOMC will make a rate decision. Chuck Butler remains steadfast in his call - read on to see if the markets are on board too... The post ...
BIS: 39.14 (+1.60), IP: 43.18 (-0.41)

Impressive Bull Run in Biotech ETFs Causes Some to Take Pause
ETFtrends.com - ETF Trends - Thu Jul 16, 10:00AM CDT
The biotechnology sector and related exchange traded funds are breaking out to new highs, but the rapid ascension has some worried about valuations. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by assets, has...
BIS: 39.14 (+1.60), BIB: 42.23 (-1.95), IBB: 267.60 (-5.98), RXD: 46.55 (+1.59), LABD: 35.92 (+2.34), ZBIO: 30.12 (+1.87)

What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 39.14 (+1.60)

Volatility in Healthcare ETFs Ahead of Supreme Court’s Obamacare Ruling
ETFtrends.com - ETF Trends - Mon Jun 15, 2:05PM CDT
The Supreme Court will give its ruling on the a key component in Obamacare that could set off short-term selling in the healthcare stocks and sector-related exchange traded funds at the end of the month. The healthcare sector has been among the...
BIS: 39.14 (+1.60), IYH: 148.57 (-1.49), FHLC: 33.88 (-0.35), RXD: 46.55 (+1.59), LABD: 35.92 (+2.34), VHT: 130.62 (-1.39), XLV: 71.78 (-0.58)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rachel Noble Joins AGS: Signals Strategy Shift

A Tactical Addition to American Global Strategies The chessboard of global security just saw a savvy new player join American Global Strategies (AGS). Rachel Noble, a name that echoes through the halls of Australia's national security apparatus, has joined AGS as Senior Advisor. This isn't your garden-variety hire—this is a strategic power move. From Down Under to the...

Boosting Employability: English Skills in Italy's Job Market

Tackling Language Barriers in Italy's Workforce If you're looking to make it big in Italy, you're facing a task that demands more than just regional expertise. The working world is no longer bound by borders, and for Italians eyeing international gigs, English fluency is a must-have. While not an absolute ticket to success, grasping English could be your career's booster...

Third Lake Parts Ways with WaterView Retail Center

Third Lake Partners Exits WaterView Retail in Florida Alright, you don't stumble across deals like this every day. Third Lake Partners just tossed the keys to their WaterView Retail Center in St. Petersburg, wrapping up the retail and residential parts under one roof with Walton Street Capital. It only took a cool five years since its completion in 2021, but hey, better...

Longevity Tour Hits East Coast: Brecka's Mission

Bringing Longevity to the East Coast This weekend, something interesting is happening on the East Coast of the U.S. Gary Brecka and his Ultimate Longevity Center (ULC) are holding a series of events in Philadelphia, New York, and Boston. Everything kicks off on November 14th. If the idea of 'live longevity' leaves you scratching your head, don’t worry—I've got you...

Abbisko's PIMJETMI® Gains FDA Nod, Boosting TGCT Treatment

PIMJETMI® Scores FDA Approval, Expanding Global Reach Well, here's something to chew on over your morning coffee—PIMJETMI® (pimicotinib) just snagged the U.S. FDA's blessing to treat tenosynovial giant cell tumor (TGCT), making it another notch on Abbisko Therapeutics' belt. This approval is a strategic home run for Abbisko and their pals at Merck KGaA, Darmstadt,...

Creative Solutions Joins FICO Marketplace, Boosts AI Edge

Creative Solutions and FICO Unite Well, we're diving into some strategic magic today. Creative Solutions International, not just your average marketing agency, has just hopped onto the FICO Marketplace platform. The word on the street is they're shaking things up with their Collections Marketing Platform. It's like giving your old financial letters a whole AI-driven paint...

Envista's $430M Senior Notes: A Market Move Decoded

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

McEwen Faces Investigation Amid Declining Production

MUX Investors on Alert as Legal Stakes Rise The gold mining world isn't exactly flooded with excitement these days, and McEwen Inc.'s (NYSE: MUX) latest dealings ain't doing much to brighten up the scenery. When their third-quarter gold output took a nosedive—a 23% drop to be exact—it caught more eyes than a bull market will. Production Guidance in Question Now,...

Kemin Unveils LYSOFORTE ENFUSIO at EuroTier 2026

Rollin' up to EuroTier 2026 with all its buzz—a place where big players in livestock production flex their muscles—Kemin Industries dropped a new ace in the feed deck: LYSOFORTE ENFUSIO. They're betting this bad boy will shake things up for poultry and pig nutritionists looking to maximize what's already on their plate without piling on more grain or feed costs....

A Gentle Stake: Colts Neck's Rural Fight Ahead

By Ryan Hughes Updated Nov 10, 2026 Category News Views 101

Michael Fazio's Gambit in Colts Neck If you're not fired up about land deals, you should be now. Michael Fazio, the owner of Synergy Stables in Colts Neck, New Jersey, is laying his cards on the table with a proposition for preserving the integrity of the township's rural landscape. Rather than cashing in on monstrous offers for high-density housing, Fazio's plan involves...